Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,034 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oncological Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide with versus without Confirmatory Bone Scan.
Jeong CW, Han JH, Kwon DD, Joung JY, Kim CS, Ahn H, Hong JH, Kim TH, Chung BH, Jeon SS, Kang M, Hong SK, Jung TY, Park SW, Yun SJ, Lee JY, Lee SH, Kang SH, Kwak C. Jeong CW, et al. Among authors: park sw. Cancer Res Treat. 2024 Apr;56(2):634-641. doi: 10.4143/crt.2023.848. Epub 2023 Dec 5. Cancer Res Treat. 2024. PMID: 38062708 Free PMC article.
Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data.
Jeong CW, Kang M, Il Jung S, Kim TH, Park SW, Joung JY, Jeon SS, Hong JH, Lee JY, Chung BH, Ahn H, Kim CS, Kwon DD, Kwak C. Jeong CW, et al. Among authors: park sw. Prostate Cancer Prostatic Dis. 2019 Mar;22(1):150-158. doi: 10.1038/s41391-018-0088-z. Epub 2018 Sep 13. Prostate Cancer Prostatic Dis. 2019. PMID: 30214035
Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting.
Jung SI, Kim MS, Jeong CW, Kwak C, Hong SK, Kang SH, Joung JY, Lee SH, Yun SJ, Kim TH, Park SW, Jeon SS, Kang M, Lee JY, Chung BH, Hong JH, Ahn H, Kim CS, Kwon DD. Jung SI, et al. Among authors: park sw. Investig Clin Urol. 2020 Jan;61(1):19-27. doi: 10.4111/icu.2020.61.1.19. Epub 2019 Dec 10. Investig Clin Urol. 2020. PMID: 31942459 Free PMC article.
Effect of pre-operative internal obturator muscle mass index in MRI on biochemical recurrence of prostate cancer patients after radical prostatectomy: a multi-center study.
Kim WT, Kang HW, Seo SP, Kim YJ, Lee SC, Kim WJ, Cho BS, Ha YS, Kwon TG, Park J, Park SC, Jeong YB, Kang TW, Park SW, Yun SJ. Kim WT, et al. Among authors: park sc, park sw, park j. BMC Urol. 2021 May 26;21(1):85. doi: 10.1186/s12894-021-00853-0. BMC Urol. 2021. PMID: 34039340 Free PMC article.
The prognostic value of the pretreatment serum albumin to globulin ratio for predicting adverse pathology in patients undergoing radical prostatectomy for prostate cancer.
Chung JW, Ha YS, Kim SW, Park SC, Kang TW, Jeong YB, Park SW, Park J, Yoo ES, Kwon TG, Seo SP, Kang HW, Kim WT, Kim YJ, Lee SC, Kim WJ, Yun SJ, Kim TH. Chung JW, et al. Among authors: park sc, park sw, park j. Investig Clin Urol. 2021 Sep;62(5):545-552. doi: 10.4111/icu.20210105. Epub 2021 Aug 4. Investig Clin Urol. 2021. PMID: 34387034 Free PMC article.
A prospective, multicenter study on the clinical effectiveness of abiraterone in metastatic castration-resistant prostate cancer in Korea: Pre- vs. post-chemotherapy.
Jeong SH, Yeon SE, Kim SY, Kwon TG, Jeon SS, Choi YD, Kwon D, Chung BH, Hong SH, Kim BH, Lee HJ, Shin SJ, Choi WS, Park SW, Kang TW, Yun SJ, Cho JS, Choi SM, Lee NR, Kwak C. Jeong SH, et al. Among authors: park sw. Investig Clin Urol. 2023 Sep;64(5):466-473. doi: 10.4111/icu.20230128. Investig Clin Urol. 2023. PMID: 37668202 Free PMC article.
4,034 results